These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas. Hill A Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560 [No Abstract] [Full Text] [Related]
43. Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats. LeSage MG; Burroughs D; Pentel PR Pharmacol Biochem Behav; 2006 Apr; 83(4):585-91. PubMed ID: 16643998 [TBL] [Abstract][Full Text] [Related]
44. Toward a nonhuman model of contingency management: effects of reinforcing abstinence from nicotine self-administration in rats with an alternative nondrug reinforcer. Lesage MG Psychopharmacology (Berl); 2009 Mar; 203(1):13-22. PubMed ID: 18946663 [TBL] [Abstract][Full Text] [Related]
45. Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats. Levin ED; Slade S; Wells C; Pruitt M; Cousins V; Cauley M; Petro A; Hampton D; Rose J Eur J Pharmacol; 2011 Jan; 650(1):256-60. PubMed ID: 20951696 [TBL] [Abstract][Full Text] [Related]
46. Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine. Kazan T; Charntikov S Neuropharmacology; 2019 Apr; 148():139-150. PubMed ID: 30611697 [TBL] [Abstract][Full Text] [Related]
47. Bupropion-varenicline interactions and nicotine self-administration behavior in rats. Hall BJ; Slade S; Wells C; Rose JE; Levin ED Pharmacol Biochem Behav; 2015 Mar; 130():84-9. PubMed ID: 25616031 [TBL] [Abstract][Full Text] [Related]
48. Effects of chronic treatment with bupropion on self-administration of nicotine + cocaine mixtures in nonhuman primates. de Moura FB; Barkin CE; Blough BE; Carroll FI; Mello NK; Kohut SJ Exp Clin Psychopharmacol; 2020 Oct; 28(5):517-526. PubMed ID: 31789555 [TBL] [Abstract][Full Text] [Related]
49. Using growth models to relate acquisition of nicotine self-administration to break point and nicotinic receptor binding. Donny EC; Lanza ST; Balster RL; Collins LM; Caggiula A; Rowell PP Drug Alcohol Depend; 2004 Jul; 75(1):23-35. PubMed ID: 15225886 [TBL] [Abstract][Full Text] [Related]
50. Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats. Kazan T; Robison CL; Cova N; Madore VM; Charntikov S Behav Brain Res; 2020 May; 385():112558. PubMed ID: 32109437 [TBL] [Abstract][Full Text] [Related]
51. The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats. Charntikov S; Pittenger ST; Pudiak CM; Bevins RA Neuropharmacology; 2018 Jun; 135():487-495. PubMed ID: 29604294 [TBL] [Abstract][Full Text] [Related]
52. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Cryan JF; Bruijnzeel AW; Skjei KL; Markou A Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231 [TBL] [Abstract][Full Text] [Related]